Showing results (171-180 of 430) with videos related to
Sort By:
Pageof 43
Seminars in Hematology|October 1, 1987
Prognostic factors in chronic lymphocytic leukemiaK R Rai, E MontserratMedicina Clinica|April 13, 1996
[Magnetic resonance of the spinal cord: a densitometric analysis]C Rozman, J M Mercader, M Rozman, et al.Medicina Clinica|February 10, 1996
[Vertebral hemangioma and quiescent myeloma: association of therapeutic significance]C Martínez, J Bladé, J Berenguer, et al.Cancer|October 1, 1977
Benign liver-cell adenoma associated with long-term administration of an androgenic-anabolic steroid (methandienone)L Hernandez-Nieto, M Bruguera, J Bombi, et al.British Journal of Haematology|November 1, 1988
Bone marrow lymphoid nodules in myeloproliferative disorders: association with the nonmyelosclerotic phases of idiopathic myelofibrosis and immunological significanceF Cervantes, A Pereira, J M Marti, et al.Sangre|April 1, 1993
[Long-term survival in chronic myeloid leukemia: frequency and fundamental characteristics in a series of 100 patients]F Cervantes, F Bosch, M J Terol, et al.Cancer|May 15, 1991
Life expectancy of patients with chronic nonleukemic myeloproliferative disordersC Rozman, M Giralt, E Feliu, et al.British Journal of Haematology|May 1, 1978
Prolymphocytic leukaemia of T-cell type: immunological, enzymatic and ultrastructural morphometric characteristicsS Woessner, R Lafuente, J Sans-Sabrafen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/ autotransplantation and who were conventionally treatedJ Bladé, J F San Miguel, M Fontanillas, et al.Acta Haematologica|January 1, 1991
Acute transformation in nonleukemic chronic myeloproliferative disorders: actuarial probability and main characteristics in a series of 218 patientsF Cervantes, D Tassies, C Salgado, et al.Pageof 43